Scarica l'app Stockscreener
206.64
0.36%
0.75
Dopo l'orario di chiusura:
206.25
-0.39
-0.19%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RVMD Giù?
Forum
Previsione
Revolution Medicines Inc Borsa (RVMD) Ultime notizie
Revolution Medicines SVP Cislini sells $158,599 in shares By Investing.com - Investing.com Australia
Form 4 Revolution Medicines Inc For: 29 September By Investing.com - Investing.com South Africa
Revolution Medicines SVP Jeff Cislini Sells 765 Shares Under 10b5-1 Trading Plan - Kalkine Media
6,000 shares from exercised options are listed for an officer’s proposed sale at Revolution Medicines (RVMD). - Stock Titan
Form 4 Revolution Medicines Inc For: 28 September By Investing.com - Investing.com South Africa
Revolution Medicines officer Mancini sells $743k in stock By Investing.com - Investing.com South Africa
Revolution Medicines officer Mancini sells $743k in stock - Investing.com
RVMD Initiates Coverage On Brookline Capital -- Rating Set to Bu - GuruFocus
Revolution Medicines Initiated at Buy by Brookline Capital - Moomoo
Brookline initiates Revolution Medicines stock with buy rating By Investing.com - Investing.com Nigeria
Brookline Capital Initiates Revolution Medicines(RVMD.US) With Buy Rating, Announces Target Price $318 - Moomoo
Form 144 REVOLUTION MEDICINES INC For: 27 September By Investing.com - Investing.com South Africa
How a UCSF scientist's persistence led to a $1 million prize and groundbreaking cancer drug - The Business Journals
Stock options are the source of 9,363 shares a Revolution Medicines (RVMD) officer proposes to sell. - Stock Titan
Form 144 Revolution Medicines For: 25 September By Investing.com - Investing.com Nigeria
Form 144 Revolution Medicines For: 25 September - Investing.com India
Is Buying Royalty Pharma Stock a Safer Way to Bet on Revolution Medicines? - Yahoo Finance
Revolution Medicines director Elizabeth Anderson sells $1.96m in stock By Investing.com - Investing.com Nigeria
Revolution Medicines director Elizabeth Anderson sells $1.96m in stock - Investing.com
Form 4 Revolution Medicines Inc For: 24 September - Investing.com India
Form 4 Revolution Medicines Inc For: 24 September By Investing.com - Investing.com Canada
Revolution Medicines Gains as New Buy Rating Adds to Recent Regulatory Momentum - Quiver Quantitative
After three earlier sales, an officer proposes selling 587 more Revolution Medicines (RVMD) shares. - Stock Titan
Revolution Medicine’s $39,800-Monthly Cancer Drug Puts Access In Focus — CEO Goldsmith Expects Insurers To Move ‘Swiftly’ To Provide Coverage - Stocktwits
Revolution Medicines Price Target Announced at $267.00/Share by Goldman Sachs - moomoo.com
Goldman Sachs Reinitiates Buy on RVMD with $267 Target Amid Biot - gurufocus.com
How (RVMD) Movements Inform Risk Allocation Models - Stock Traders Daily
Revolution Medicines (RVMD) Deepens RAS(ON) Bet With Breakthrough PDAC Combo – But Is Risk Repricing? - Yahoo Finance
AIM ImmunoTech Highlights Ampligen’s Potential Role in the Evolving Pancreatic Cancer Treatment Landscape Following FDA Approval of Revolution Medicines’ Daraxonrasib - markets.businessinsider.com
Form 4 Revolution Medicines Inc For: 22 September By Investing.com - Investing.com Australia
Revolution Medicines (RVMD) Wins FDA Breakthrough Status For RASONQUE - Yahoo Finance
Revolution Medicines (NASDAQ: RVMD) director plans stock sale from option exercise - Stock Titan
Here's How Much $1000 Invested In Revolution Medicines 5 Years Ago Would Be Worth Today - Benzinga
AIM ImmunoTech Highlights Ampligen’s Potential Role in the - GlobeNewswire
Illinois grew the science behind a breakthrough cancer drug — but couldn’t hold onto the company - Crain's Chicago Business
RVMD Maintained by B of A Securities -- Price Target Raised to $265 - GuruFocus
Client Revolution Medicines Secures 672,000-Square-Foot Redwood City Lease in former Google Space - Procopio
Revolution Medicines, Inc. (RVMD) Stock Analysis: A Promising 31.56% Upside in the Precision Oncology Space - DirectorsTalk Interviews
Revolution Medicines, Inc.(NasdaqGS: RVMD) added to FTSE All-World Index - marketscreener.com
This Insider Has Just Sold Shares In Revolution Medicines - simplywall.st
Revolution Medicines chief development officer sells $67,940 in stock By Investing.com - Investing.com South Africa
Revolution Medicines Senior Advisor Executes Stock Sales via 10b5-1 Plan to Cover RSU Taxes - Kalkine Media
Revolution Medicines officer sells $353,449 in shares By Investing.com - Investing.com Nigeria
Revolution Medicines chief development officer sells $67,940 in stock - Investing.com
Revolution Medicines’ senior advisor sells $1.1m in stock By Investing.com - Investing.com South Africa
Revolution Medicines CFO Jack Anders sells $807,513 in stock By Investing.com - Investing.com Australia
Revolution Medicines’ senior advisor sells $1.1m in stock - Investing.com
Revolution Medicines’ Jeff Cislini sells $670k in common stock By Investing.com - Investing.com Australia
Revolution Medicines COO Margaret Horn sells $989,612 of common stock By Investing.com - Investing.com Australia
Revolution Medicines CEO Mark Goldsmith sells $2.78m in stock - Investing.com
Revolution Medicines’ Jeff Cislini sells $670k in common stock - Investing.com
Revolution Medicines CFO Jack Anders sells $807,513 in stock - Investing.com
Revolution Medicines CEO Mark Goldsmith sells $2.78m in stock By Investing.com - Investing.com Canada
Revolution Medicines (RVMD) exec sells 1,774 shares, keeps 39,575 RSUs - Stock Titan
Revolution Medicines (RVMD) legal chief makes pre-set stock sale for taxes - Stock Titan
0.20%
0.62%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):